Ifosfamide Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 1 g/vial,2 g/vial, 3 g/vial
Reference Brands: Ifex® (US), Holoxan® (EU)
Category:
Oncology Cancer Care
Ifosfamide Injection is a cytotoxic agent used in combination chemotherapy for testicular cancer, sarcomas, and other solid tumors. Available in EU-GMP and USFDA-compliant injectable formulations (1 g, 2 g, and 3 g vials), it is offered for B2B supply, contract manufacturing, and licensing. Our product comes with full regulatory support including CTD dossier, CoA, and stability data. Ideal for importers, hospital procurement, and oncology distributors in regulated markets.
Ifosfamide is available in Injection
and strengths such as 1 g/vial,2 g/vial, 3 g/vial.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Ifosfamide is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Ifosfamide can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Ifosfamide Injection is a cytotoxic alkylating agent used in the treatment of germ cell testicular cancer, sarcomas, lymphomas, and other solid tumors. Available in sterile powder form for reconstitution (1 g, 2 g, 3 g vials), our Ifosfamide is manufactured under EU-GMP and USFDA-compliant facilities. Suitable for B2B supply, hospital tenders, private labeling, and licensing agreements, it is supported with full CTD dossiers, CoA, stability data, and GMP certification. Alcohol-free, stable, and ready for international markets, our Ifosfamide injection is ideal for global distributors, procurement agencies, and oncology-focused partners seeking high-quality injectable chemotherapy formulations.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing